341424 <common-name>N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-[(4-prop-2-enyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide</common-name> <description>N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-[(4-prop-2-enyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide is a chemical compound with the formula C25H21N5OS3. With an average molecular weight of 503.70 g/mol, N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-[(4-prop-2-enyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide is a heavy molecule.</description> <cas>618879-85-9</cas> <pubchem-id>1891104</pubchem-id> <chemical-formula>C25H21N5OS3</chemical-formula> <weight>503.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T01:48:01Z</created-at> <updated-at type="dateTime">2026-08-31T01:48:01Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)CSC4=NN=C(N4CC=C)C5=CC=CS5</moldb-smiles> <moldb-formula>C25H21N5OS3</moldb-formula> <moldb-inchi>InChI=1S/C25H21N5OS3/c1-3-12-30-23(20-5-4-13-32-20)28-29-25(30)33-15-22(31)26-18-9-7-17(8-10-18)24-27-19-11-6-16(2)14-21(19)34-24/h3-11,13-14H,1,12,15H2,2H3,(H,26,31)</moldb-inchi> <moldb-inchikey>GCUGGAWFNPIEGG-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">503.0908238</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM337317</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-[(4-prop-2-enyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Benzothiazoles</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0291822</sync-id> <structure-inchikey>GCUGGAWFNPIEGG-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>20000004000020000800000000800000000002000000100000000001040000000000010000000000004000000002180000000000000000000000000000000000000000004000000000000000000000020000010000200000000000010000002000000210000000010000000100400840000000108000040020000000004000000000040000400804000000004200080880000000000000000000000000000000000000000000200000200080000000000000000410000000000012800000000000001002000000000000000040002040000000000002000000220000000000000008900000005000040000000000400020004010000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEH QCgAAAADAwZAKAAAAAMEEEAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAA AAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBwBoAAAAAwIBBgAoAAAA AwQIACgAAAADAgYAYAAAAAICEAAgAAAAAgZAKAAAAAMEB0AoAAAAAwMHQCgA AAADAwZAKAAAAAMEB0AoAAAAAwMGAGAAAAACAgYAaAAAAAMDAQYAaAAAAAMC AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBEEAoAAAAAwIL AAEAAQJoDAIDaAwDBGgMBAVoDAUGaAwEB2gMBwhoDAgJaAwICiAKC2gMCwxo DAwNaAwNDmgMDg9oDA0QIBARIBESKAIREwATFAAUFQAVFmgMFhdoDBcYaAwY GWgMGRoAGhsAGxwIAhgdIB0eaAweH2gMHyBoDCAhaAwGAWgMCQNoDA8KaAwZ FWgMIR1oDEIFAAAABgEGBQQDAgUHBAMJCAYLDA0ODwoFFhUZGBcFHh0hIB8X BAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:41:22Z</structure-indexed-at> </compound>